Literature DB >> 19258503

Inhibition of constitutively activated nuclear factor-kappaB induces reactive oxygen species- and iron-dependent cell death in cutaneous T-cell lymphoma.

Michael K Kiessling1, Claus D Klemke, Marcin M Kaminski, Ioanna E Galani, Peter H Krammer, Karsten Gülow.   

Abstract

Aberrant signaling of the nuclear facotr (NF-kappaB) pathway has been identified as a mediator of survival and apoptosis resistance in leukemias and lymphomas. Here, we report that cell death of cutaneous T-cell lymphoma cell lines induced by inhibition of the NF-kappaB pathway is independent of caspases or classic death receptors. We found that free intracellular iron and reactive oxygen species (ROS) are the main mediators of this cell death. Antioxidants such as N-Acetyl-l-cysteine and glutathione or the iron chelator desferrioxamine effectively block cell death in cutaneous T-cell lymphoma cell lines or primary T cells from Sézary patients. We show that inhibition of constitutively active NF-kappaB causes down-regulation of ferritin heavy chain (FHC) that leads to an increase of free intracellular iron, which, in turn, induces massive generation of ROS. Furthermore, direct down-regulation of FHC by siRNA caused a ROS-dependent cell death. Finally, high concentrations of ROS induce cell death of malignant T cells. In contrast, T cells isolated from healthy donors do not display down-regulation of FHC and, therefore, do not show an increase in iron and cell death upon NF-kappaB inhibition. In addition, in a murine T-cell lymphoma model, we show that inhibition of NF-kappaB and subsequent down-regulation of FHC significantly delays tumor growth in vivo. Thus, our results promote FHC as a potential target for effective therapy in lymphomas with aberrant NF-kappaB signaling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19258503     DOI: 10.1158/0008-5472.CAN-08-3221

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  35 in total

1.  Oh the irony: Iron as a cancer cause or cure?

Authors:  Susan P Foy; Vinod Labhasetwar
Journal:  Biomaterials       Date:  2011-10-01       Impact factor: 12.479

Review 2.  Targeting cancer vulnerabilities with high-dose vitamin C.

Authors:  Bryan Ngo; Justin M Van Riper; Lewis C Cantley; Jihye Yun
Journal:  Nat Rev Cancer       Date:  2019-05       Impact factor: 60.716

Review 3.  NFκB function and regulation in cutaneous T-cell lymphoma.

Authors:  Tzu-Pei Chang; Ivana Vancurova
Journal:  Am J Cancer Res       Date:  2013-11-01       Impact factor: 6.166

4.  Bortezomib induces nuclear translocation of IκBα resulting in gene-specific suppression of NF-κB--dependent transcription and induction of apoptosis in CTCL.

Authors:  Ashish Juvekar; Subrata Manna; Sitharam Ramaswami; Tzu-Pei Chang; Hai-Yen Vu; Chandra C Ghosh; Mahmut Y Celiker; Ivana Vancurova
Journal:  Mol Cancer Res       Date:  2011-01-11       Impact factor: 5.852

5.  NEMO-binding domain peptide inhibits constitutive NF-κB activity and reduces tumor burden in a canine model of relapsed, refractory diffuse large B-cell lymphoma.

Authors:  Anita Gaurnier-Hausser; Reema Patel; Albert S Baldwin; Michael J May; Nicola J Mason
Journal:  Clin Cancer Res       Date:  2011-05-24       Impact factor: 12.531

6.  DMF: a promising therapeutic option in CTCL.

Authors:  Ivana Vancurova
Journal:  Blood       Date:  2016-08-11       Impact factor: 22.113

7.  Role of labile iron in the toxicity of pharmacological ascorbate.

Authors:  Juan Du; Brett A Wagner; Garry R Buettner; Joseph J Cullen
Journal:  Free Radic Biol Med       Date:  2015-04-07       Impact factor: 7.376

Review 8.  Redox regulation in cancer: a double-edged sword with therapeutic potential.

Authors:  Asha Acharya; Ila Das; Des Chandhok; Tapas Saha
Journal:  Oxid Med Cell Longev       Date:  2010 Jan-Feb       Impact factor: 6.543

Review 9.  The role of iron homeostasis and iron-mediated ROS in cancer.

Authors:  Jia-Fu Ying; Ze-Bei Lu; Luo-Qin Fu; Yu Tong; Zhen Wang; Wei-Fen Li; Xiao-Zhou Mou
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

10.  Bcl3 regulates pro-survival and pro-inflammatory gene expression in cutaneous T-cell lymphoma.

Authors:  Tzu-Pei Chang; Ivana Vancurova
Journal:  Biochim Biophys Acta       Date:  2014-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.